Histamine Phosphate has 6 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Astemizole, Chlorpheniramine, Dopamine Agonists. Patients taking Histamine Phosphate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 6
- Moderate
- 6
Moderate (6)
- Histamine Phosphate + Astemizole— Antihistamine that suppresses response to histamine. Duration of suppression can be as long as 40 days.
- Histamine Phosphate + Chlorpheniramine— Antihistamine that suppresses response to histamine. Duration of suppression may be as little as 24 hours.
- Histamine Phosphate + Dopamine Agonists— Intravenous infusion of dopamine inhibits skin test responses to histamine.
- Histamine Phosphate + Ephedrine— Parenteral beta 2 agonist that decreases allergen-induced wheal and may reduce whealing capacity to histamine.
- Histamine Phosphate + Propranolol— Beta blocking agent that can significantly increase skin test reactivity to histamine.
- Histamine Phosphate + Terbutaline— Oral beta 2 agonist that decreases allergen-induced wheal and may reduce whealing capacity to histamine.